Showing 1 – 2 of 2
Relevance | Newest | Oldest |
  • JAMA Original Investigation
    April 12, 2024

    Non鈥揌igh-Density Lipoprotein Cholesterol Levels From Childhood to Adulthood and Cardiovascular Disease Events

    Feitong聽Wu,聽PhD; David R.听Jacobs聽Jr,聽PhD; Stephen R.听Daniels,聽MD, PhD; Mika聽K盲h枚nen,聽MD, PhD; Jessica G.听Woo,聽PhD; Alan R.听Sinaiko,聽MD; Jorma S. A.听Viikari,聽MD, PhD; Lydia A.听Bazzano,聽MD, PhD; Julia聽Steinberger,聽MD; Elaine M.听Urbina,聽MD, MS; Alison J.听Venn,聽PhD; Olli T.听Raitakari,聽MD, PhD; Terence聽Dwyer,聽MD, MBBS, MPH; Markus聽Juonala,聽MD, PhD; Costan G.听Magnussen,聽PhD
    Abstract Full Text
    is active quiz online first
    JAMA. 2024; 10.1001/jama.2024.4819

    This study of individual participant data from 6 pooled cohorts assesses whether resolution of elevated childhood non鈥揾igh-density lipoprotein cholesterol (non鈥揌DL-C) by adulthood is associated with reduced risk of clinical cardiovascular disease (CVD) events.

  • JAMA Cardiology Research Letter
    June 1, 2016

    Predictive Score for 30-Day Readmission or Death in Heart Failure

    Quan L.听Huynh,聽BMed, PhD; Kazuaki聽Negishi,聽MD, PhD; Leigh聽Blizzard,聽PhD; Kristy聽Sanderson,聽PhD; Alison J.听Venn,聽PhD; Thomas H.听Marwick,聽MBBS, PhD, MPH
    Abstract Full Text
    free access
    JAMA Cardiol. 2016; 1(3):362-364. 10.1001/jamacardio.2016.0220

    This study combines specific clinical and nonclinical factors to reliably predict 30-day readmission or death in heart failure.